Xenon Pharmaceuticals (XENE) Other Working Capital Changes (2020 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Other Working Capital Changes came in at -$349000.0 in Q1 2026, down 13.68% year-on-year from -$404313.2 in Q1 2025, and down 4.18% on a QoQ basis from -$335000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 6 years of Other Working Capital Changes data on file, last reported at -$349000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 13.68% year-over-year to -$349000.0 in Q1 2026; TTM through Mar 2026 was -$1.3 million, a 8.77% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 6.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$349000.0, down from -$335000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for XENE reached as high as $6.5 million in Q4 2022 and fell as low as -$6.6 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $855529.4 across 5 years, with a median of $673000.0 in 2024.
- Across the five-year window, Other Working Capital Changes soared 72.75% in 2022 and declined 13.68% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$600000.0 in 2022, then jumped by 47.0% to -$318000.0 in 2024, then slipped by 5.35% to -$335000.0 in 2025, then retreated by 4.18% to -$349000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$349000.0 in Q1 2026, -$335000.0 in Q4 2025, and -$337000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -349,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Mar 31, 2026 | -349,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | -318,000.00 |
| Dec 31, 2024 | -318,000.00 |
| Dec 31, 2024 | -318,000.00 |
| Sep 30, 2024 | -313,000.00 |
| Sep 30, 2024 | -313,000.00 |